KLOW (BPC-157, TB500, GHK-Cu, KPV)

KLOW is a research peptide blend typically combining BPC-157, TB-500, GHK-cu, and KPV, studied for its potential to support tissue repair and recovery. In experimental settings, it is investigated for its regenerative and anti-inflammatory effects.

Key Benefits

•Complete tissue + gut + skin repair

•Strong anti-inflammatory support

•Enhanced joint & tendon healing

•Skin quality enhancement

Science

•Adds KPV’s inflammation control to the Glow formula

•Multi-pathway repair with angiogenesis + collagen + cytokine regulation

Dosing

•2–4 mg/day

Cycle Length

•6–12 weeks

Vials Needed

•3 mg/day × 28 days → 84 mg

•4-week cycle → ~1–2 vials